Biomarin Pharmaceutical Inc

BMRN · US

Held by 3 big investorsLargest: Norway NBIM

Biomarin Pharmaceutical Inc is held by 3 of the 24 tracked investors in their latest 13F filings. The largest position is Norges Bank's at $470M, 0.05% of that portfolio. Versus the prior quarter, 3 added, 0 trimmed and 0 bought new.

Big investors holding this stock

Latest 13F of the 24 tracked investors. Common shares only.

Investor	Value ($)	Weight	Rank in portfolio	vs prior quarter
Norges Bank Norway's sovereign wealth fund · Q2 2026weight 0.05% · Q2 2026	470M	0.05%	#326	▲ 9%
Viking Global Investors Andreas Halvorsen's hedge fund · Q2 2026weight 1.24% · Q2 2026	436M	1.24%	#29	▲ 8%
Bridgewater Associates Hedge fund founded by Ray Dalio · Q2 2026weight 0.06% · Q2 2026	15.7M	0.06%	#252	▲ 33%

Investor

Value ($)

Weight

Rank in portfolio

vs prior quarter

Norges Bank

Norway's sovereign wealth fund · Q2 2026weight 0.05% · Q2 2026

470M

0.05%

#326

▲ 9%

Viking Global Investors

Andreas Halvorsen's hedge fund · Q2 2026weight 1.24% · Q2 2026

436M

1.24%

#29

▲ 8%

Bridgewater Associates

Hedge fund founded by Ray Dalio · Q2 2026weight 0.06% · Q2 2026

15.7M

0.06%

#252

▲ 33%

Reported value by investor (13F)

Questions

Which big investors own Biomarin Pharmaceutical Inc?

Norges Bank ($470M), Viking Global Investors ($436M), Bridgewater Associates ($15.7M), per their latest 13F filings.

Does Warren Buffett own Biomarin Pharmaceutical Inc?

Berkshire Hathaway did not report it in its latest 13F.

Does Korea's National Pension Service own Biomarin Pharmaceutical Inc?

Not in its latest 13F.

Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.